| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.088 | 0.002 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.62 | 0.003 |